Well, I and you, both want to know what Merck's plan is for this setting, and I really do not know what the hold-up is, other than them thinking they are going to get more money and more use out of a combination study...I guess we'll see.
BTW, while you're here....could you PLEASE clear up biotech_"researchers" obvious confusion and misquoting AP regarding the OS data (he continues to insist the abstract says something it didnt).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.